HomeWebinarsMilliplex Assays

Milliplex Assays


It aims to show how xMAP technology and multiplex immunoassays can be successfully integrated into your disease research workflow with a focus on SARS-CoV-2 related cytokine storm syndrome.


Cláudia Emanuele


Field Marketing Specialist

Adriana Nuñez


Field Marketing Specialist

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.